VP OF REGULATORY & CLINICAL AFFAIRS
Dr. Beatty has nearly 25 years of experience in the formulation and execution of scientific and regulatory strategies for drug, biologic, and device development programs. She also has extensive experience leading development teams from discovery to post-approval, as well as programs for the treatment of rare and life-threatening diseases.

Dr. Beatty previously worked at a scientific and regulatory consulting company (Cardinal Health Regulatory Sciences, formerly Beckloff Associates), where she established and managed regulatory affairs, clinical and nonclinical development, and medical writing groups; and as a project manager for Invitrogen-ThermoFisher Scientific (formerly Molecular Probes), a biotechnology products developer/manufacturer with responsibilities for the coordination of new product introduction from product concept to packaged product. Other career highlights include involvement in numerous product approvals; technical liaison between company scientists, collaborators, and clientele; experimental strategy consultation; drug discovery, and management of academic research laboratory activities. Dr. Beatty holds a PhD in Chemistry/Biochemistry from the University of Missouri – Kansas City.